PA-PENNENGINEERING
PennEngineering® a global leader in innovative fastening solutions, has announced the expansion of its operations located in Galway City, Ireland.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240722804353/en/
(Photo: Business Wire)
This significant extension is set to create 70 new jobs over the next five years, in support of the company's commitment to growth and community development.
The €14 million expansion project, which involves the construction of a new building, includes a state-of-the-art technology and training centre as well as testing laboratories and customer experience centre that will enhance PennEngineering’s capacity to meet the increasing demand for engineering fastening solutions. The new jobs created will span a variety of roles, including manufacturing, engineering, training and more, offering diverse opportunities for local talent.
The expansion project is supported by the Irish Government through IDA Ireland.
Minister of State for Trade Promotion, Digital and Company Regulation, Dara Calleary TD said: “I am pleased to welcome this announcement from PennEngineering which will see the creation of 70 jobs as part of a major expansion project. Investments such as this continue to advance Galway’s position, in particular, as a global hub. I am pleased to welcome this announcement and wish PennEngineering every success.”
“We are thrilled to expand our operations in Galway,” said Mary Ann Fleming, President, PennEngineering Europe. “This investment reflects our confidence in the potential for growth in the region and our commitment to contributing to the local economy. We look forward to welcoming new members to our team and continuing to innovate in the world of fastening technology. Our on-site manufacturing also continues to expand with the introduction of new products, continuing our 82-year history of product innovation in self-clinch fasteners. Supporting training and development of our people and job creation are priorities for us, and this expansion is key to this initiative. As part of this growth announcement, we welcome the board of PennEngineering on site for their biannual meeting and wish them well as they strategise for the future of our global company.”
“Our long-standing partnership with Ireland and the IDA spans over 20 years, and their support has been invaluable in fostering the growth and development of our business in Europe,” according to Pete George, PennEngineering CEO.
The expansion is expected to be completed by January 2025. PennEngineering plans to begin the recruitment process immediately, with job openings to be posted on the company’s website and local job boards.
Mary Buckley, Executive Director of IDA Ireland, said: “PennEngineering has been in Galway since 2001, and this announcement today highlights their ongoing commitment to the West Region. The operation is already a recognised centre of excellence within the global organisation and this 4000m² expansion and 70 jobs further enhances its strategic capabilities in Galway. I wish the PennEngineering team continued success.”
For more information about the expansion and job opportunities, please visit www.pemnet.com/eu/.
About PennEngineering: https://www.penn-eng.com/
Since 1942, PennEngineering® has enjoyed a sustained reputation as the global leader in the fastening industry. The company's brands, PEM®, PROFIL®, Sherex®, PennAuto®, are considered the premier manufacturer for self clinching and other mechanically attached fasteners. Haeger®, for installation systems and Heyco® for molded and stamped products.
PennEngineering’s steadfast commitment to engineering expertise and global innovation ensures that we continue to grow our portfolio with technologies and solutions that allow our customers to not only keep pace with marketplace challenges – but exceed them.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240722804353/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
1NCE Continues Growth and Expands Its Software, AI and Services Offering7.1.2026 14:15:00 CET | Press release
In 2025 1NCE added another 10 million endpoints to its foundational IoT platform; now manages 40+ million intelligent products for 30,000 customers in 17 industries. Introduces new software, 1NCE Insights, the AI + IoT fusion of intelligence from its network that gives analytics and benchmark data on how customers can better setup, manage and optimize their device estates. 1NCE, a company offering a plug-and-play platform for creating and managing the world’s best IoT products, reports another strong growth year, adding another 10 million endpoints. The company now manages 40+ million intelligent products for 30,000+ customers across 17 industries. 1NCE’s software and connectivity platform has become a new industry standard, delivering hassle-free IoT in 170+ countries and regions. The company has a unique vantage point in the IoT ecosystem, with four billion data records per day collected through 250+ streams on the world’s largest IoT network in the cloud. The company launched a new
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 14:00:00 CET | Press release
Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release
FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom